Today: 8 June 2026
Gold price forecast for 2026: Banks map a $4,275-$5,000 range after bullion’s blockbuster year
1 January 2026
2 mins read

Gold price forecast for 2026: Banks map a $4,275-$5,000 range after bullion’s blockbuster year

NEW YORK, January 1, 2026, 14:46 ET

  • Analysts say gold still has room to run in 2026 if U.S. rates keep drifting lower and central banks stay active buyers.
  • Major banks’ outlooks keep prices elevated, but some warn gains may slow as official-sector and ETF demand cools.
  • Year-end margin hikes on metal futures underscore how quickly leverage can amplify swings in precious metals.

Gold and other precious metals may have room for further gains in 2026 as interest rates are expected to fall, analysts said, after gold climbed 66% in 2025. The rally pushed bullion to record highs on economic and geopolitical risks. Tim Waterer, chief market analyst at broker KCM Trade, said: “The key fundamental drivers of central bank demand and investor positioning ahead of expected lower U.S. rates in 2026 remain intact.” Reuters

That matters now because investors start the year resetting hedge ratios and rebalancing portfolios after one of the most volatile year-end stretches in memory. Gold is often treated as a safe haven, meaning a place investors park money when markets get nervous.

Volatility has also been fed by tighter rules on leveraged trading. CME Group said it would raise performance bond requirements for metal futures effective after the close on Dec. 31, lifting the cash traders must post to keep positions open. 

Spot gold fell 0.78% to $4,312.39 an ounce on Dec. 31, while spot silver dropped 7.1% to $71.04, Reuters data showed. 

A Reuters poll of 39 analysts and traders in October put the median forecast for gold’s 2026 annual average at $4,275 an ounce, the first time the survey topped $4,000. The poll’s median 2025 forecast was $3,400. 

Bank of America lifted its 2026 gold forecast to $5,000 an ounce, with an average of $4,400, and said it still expected further upside even while flagging risks of a near-term correction. The bank also raised its 2026 view for silver to $65 an ounce. 

Goldman Sachs projected gold would climb 14% to $4,900 an ounce by December 2026 in its base case, saying structurally high central bank demand and support from Federal Reserve rate cuts should help keep prices firm. 

Morgan Stanley forecast gold at $4,800 an ounce by the fourth quarter of 2026, but said gains may slow if central banks and exchange-traded funds reduce purchases. ETFs are funds that trade like shares and can hold bullion for investors. 

JPMorgan said gold could average $5,055 an ounce by the fourth quarter of 2026, basing its forecast on assumptions about investor demand and central-bank buying averaging about 566 tons a quarter in 2026. It reiterated a longer-term target of $6,000 an ounce by 2028. 

Gold ended 2025 around $4,326.55 an ounce and was up about 65% on the year, Reuters reported, as investors leaned on central-bank buying, exchange-traded fund inflows and safe-haven demand. Silver finished around $72.02 after touching a record $83.62, while platinum ended near $2,020.11 after peaking at $2,478.50. Analysts said strategic stockpiling and competition for key metals could keep prices supported into 2026. 

Forecasts hinge on how far and how fast U.S. rates fall. Gold pays no interest, so it tends to look better when real yields — inflation-adjusted bond returns — slide and the dollar weakens.

For now, the range of big-bank calls highlights both strong underlying demand and the risk of sudden air pockets when leverage is pulled back. Traders will be watching early-2026 signals on central-bank activity, ETF flows and whether the market can sustain prices above $4,000 without fresh shocks.

Stock Market Today

  • IperionX's Titan DFS Highlights US Critical Mineral Supply Potential
    June 8, 2026, 10:13 AM EDT. IperionX (ASX:IPX) released a Definitive Feasibility Study (DFS) for its Titan project in Tennessee, outlining a 14-year mine plan with an after-tax net present value (NPV8) of US$813 million and an internal rate of return (IRR) of 39%. The project aims to supply titanium, zircon, and heavy rare earth elements like dysprosium, terbium, and yttrium, crucial for U.S. supply chains. The DFS confirms Titan's scale but also highlights the challenge of securing US$381.3 million in development capital. Despite rising losses and no current revenue, the study sharpens IperionX's vision of a domestic critical minerals hub. Market reactions show mixed views amid financing and execution risks, positioning the stock as potentially undervalued yet dependent on funding progress and project delivery.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
No alien signal: most sensitive radio scan of interstellar comet 3I/ATLAS comes up empty
Previous Story

No alien signal: most sensitive radio scan of interstellar comet 3I/ATLAS comes up empty

Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020
Next Story

Chevron stock today: CVX steadies near $152 as oil logs steepest annual drop since 2020

Go toTop